Image

Prediction of PEP Based on the Appearance of the Major Duodenal Papilla

Prediction of PEP Based on the Appearance of the Major Duodenal Papilla

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This observational, prospective study aims at evaluating how the occurrence of post-Endoscopic Retrograde CholangioPancreatography (ERCP) acute pancreatitis (PEP) could be influenced by difficult biliary cannulation that might be previously assessed by the morphological appearance of native major papilla in all the patients undergoing ERCP.

The rate of successful biliary cannulation across papilla types could be used as intraprocedural quality and competence metrics during training. Moreover, recognizing difficult papillae could allow reserving those to experts to decrease the odds of failed cannulation.

Eligibility

Inclusion Criteria:

  • Patients with native duodenal papilla;
  • Any indication to ERCP +/- biliary sphincterotomy of duodenal major papilla;
  • Patients able to provide a written informed consent

Exclusion Criteria:

  • ERCP performed for disorders unrelated to biliary tract;
  • Previous upper gastrointestinal tract surgery;
  • Presence of a duodenal stricture (either malignant or benign);
  • Presence of a malignant infiltration of the papilla;
  • Concomitant anticoagulant and/or P2Y12 inhibitors therapy (clopidogrel, prasugrel, ticagrelor) that precludes the treatment;
  • INR > 1.5;
  • Platelets count < 80000/mm3;
  • Unwillingness to sign written informed consent.

Study details
    Post-ERCP Acute Pancreatitis

NCT05800626

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.